Search Results 2251-2260 of 14830 for anti-TNF drugs

1. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 - Mayo Clinic

   Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2- ...

2. A Study of Lenvatinib for Treating Patients with Metastatic or Advanced Pheochromocytoma or Paraganglioma that Cannot be Removed by Surgery - Mayo Clinic

   ... treatment for their cancer; NOTE: adjuvant anti-estrogen/hormonal therapy for breast cancer is allowed. Participating Mayo Clinic locations. Study statuses ...

3. Sunscreen Agent (Topical Application Route) Description and Brand Names - Mayo Clinic

   Chemical sunscreen agents protect you from the sun by absorbing the ultraviolet (UV) and visible sun rays, while physical sunscreen agents reflect, scatter, ...

4. Technetium Tc 99m Medronate (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Entrectinib (Oral Route) Precautions - Mayo Clinic

   Cancer medicines can cause constipation, diarrhea, nausea, or vomiting in most people, sometimes even after receiving medicines to prevent it. Ask your doctor ...

6. A Study to Evaluate CTX110 in Subjects with Relapsed or Refractory B-Cell Malignancies - Mayo Clinic

   For NHL patients: Use of systemic anti-tumor therapy or investigational agent within 14 days or 5 half-lives, whichever is longer, of enrollment. For B cell ...

7. Estradiol (Transdermal Route) Proper Use - Mayo Clinic

   Your doctor may adjust your dose as needed. Children—Use is not recommended. For the treatment of low estrogen levels: For transdermal dosage form (patch):.

8. Iothalamate Meglumine (Injection Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. Efgartigimod Alfa And Hyaluronidase-Qvfc (Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Drugs and Supplements · Efgartigimod Alfa And ... anti-acetylcholine receptor (AChR) antibody positive. ... Drugs & Supplements; Efgartigimod Alfa And ...

10. Indomethacin (Rectal Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...